Trials / Withdrawn
WithdrawnNCT03902379
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer
Web-Based Coping and Communication Skills Intervention for Women Who Are Newly Diagnosed With Gynecological Cancer: A Pilot Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Rutgers, The State University of New Jersey · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This pilot clinical trial studies how well web-based coping and communication skills intervention works in improving psychological adaptation in patients with gynecological cancer. Web-based intervention, such as coping and communication skills intervention, may help doctors to get a better understanding of ways to help gynecological cancer patients cope with their cancer experience.
Detailed description
PRIMARY OBJECTIVES: I. To examine the feasibility and acceptability of an online coping and communication skills intervention (CCI). II. To collect pilot data on the impact of online CCI on global and cancer-specific distress. OUTLINE: Patients complete 3 modules of online CCI intervention. After completion of study, patients are followed up at 2 months.
Conditions
- Endometrial Carcinoma
- Stage 0 Fallopian Tube Cancer AJCC v7
- Stage I Fallopian Tube Cancer AJCC v6 and v7
- Stage I Ovarian Cancer AJCC v6 and v7
- Stage IA Fallopian Tube Cancer AJCC v6 and v7
- Stage IA Ovarian Cancer AJCC v6 and v7
- Stage IB Fallopian Tube Cancer AJCC v6 and v7
- Stage IB Ovarian Cancer AJCC v6 and v7
- Stage IC Fallopian Tube Cancer AJCC v6 and v7
- Stage IC Ovarian Cancer AJCC v6 and v7
- Stage II Cervical Cancer AJCC v7
- Stage II Fallopian Tube Cancer AJCC v6 and v7
- Stage II Ovarian Cancer AJCC v6 and v7
- Stage II Uterine Corpus Cancer AJCC v7
- Stage IIA Cervical Cancer AJCC v7
- Stage IIA Fallopian Tube Cancer AJCC v6 and v7
- Stage IIA Ovarian Cancer AJCC V6 and v7
- Stage IIA1 Cervical Cancer AJCC v7
- Stage IIA2 Cervical Cancer AJCC v7
- Stage IIB Cervical Cancer AJCC v6 and v7
- Stage IIB Fallopian Tube Cancer AJCC v6 and v7
- Stage IIB Ovarian Cancer AJCC v6 and v7
- Stage IIC Fallopian Tube Cancer AJCC v6 and v7
- Stage IIC Ovarian Cancer AJCC v6 and v7
- Stage III Cervical Cancer AJCC v6 and v7
- Stage III Fallopian Tube Cancer AJCC v7
- Stage III Ovarian Cancer AJCC v6 and v7
- Stage III Primary Peritoneal Cancer AJCC v7
- Stage III Uterine Corpus Cancer AJCC v7
- Stage IIIA Cervical Cancer AJCC v6 and v7
- Stage IIIA Fallopian Tube Cancer AJCC v7
- Stage IIIA Ovarian Cancer AJCC v6 and v7
- Stage IIIA Primary Peritoneal Cancer AJCC v7
- Stage IIIA Uterine Corpus Cancer AJCC v7
- Stage IIIB Cervical Cancer AJCC v6 and v7
- Stage IIIB Fallopian Tube Cancer AJCC v7
- Stage IIIB Ovarian Cancer AJCC v6 and v7
- Stage IIIB Primary Peritoneal Cancer AJCC v7
- Stage IIIB Uterine Corpus Cancer AJCC v7
- Stage IIIC Fallopian Tube Cancer AJCC v7
- Stage IIIC Ovarian Cancer AJCC v6 and v7
- Stage IIIC Primary Peritoneal Cancer AJCC v7
- Stage IIIC Uterine Corpus Cancer AJCC v7
- Stage IIIC1 Uterine Corpus Cancer AJCC v7
- Stage IIIC2 Uterine Corpus Cancer AJCC v7
- Stage IV Cervical Cancer AJCC v6 and v7
- Stage IV Fallopian Tube Cancer AJCC v6 and v7
- Stage IV Ovarian Cancer AJCC v6 and v7
- Stage IV Primary Peritoneal Cancer AJCC v7
- Stage IV Uterine Corpus Cancer AJCC v7
- Stage IVA Cervical Cancer AJCC v6 and v7
- Stage IVA Uterine Corpus Cancer AJCC v7
- Stage IVB Cervical Cancer AJCC v6 and v7
- Stage IVB Uterine Corpus Cancer AJCC v7
- Uterine Carcinosarcoma
- Uterine Corpus Sarcoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Internet-Based Intervention | Receive CCI intervention |
| OTHER | Quality-of-Life Assessment | Ancillary studies |
| OTHER | Questionnaire Administration | Ancillary studies |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2016-07-27
- Primary completion
- 2020-05-31
- Completion
- 2020-05-31
- First posted
- 2019-04-04
- Last updated
- 2021-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03902379. Inclusion in this directory is not an endorsement.